Deblina Sarkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Deblina Sarkar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Mitali Chatterjee
Institute of Postgraduate Medical Education and Research
2 shared publications - Azra Aleta
Pharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria
1 shared publication - Deep Goswami
Department of Pharmacology, Institute of Post Graduate Medical Education and Research (IPGMER), Kolkata, India
1 shared publication - Elisabeth Schrödl
Pharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria
1 shared publication - Katrin Staniek
Pharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria
1 shared publication - Lars Gille
Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria
1 shared publication
Latest Publications
- Open Access
Sterol Endoperoxides and Their Antileishmanial Effects: Influence on Viability, Oxygen Metabolism and Sterol Synthesis
Leishmaniasis is a global health issue, especially in tropical and subtropical areas, with treatment challenges due to the development of resistance to current drugs. This has prompted the search for new antileishmanial compounds. Endoperoxides, due to parasites’ reliance on external iron and susceptibility to oxidative stress, are promising antileishmanial compounds. This study evaluated two sterol endoperoxides—ergosterol endoperoxide (ErgoEP) and dehydrocholesterol endoperoxide (DHCholEP)—for their antileishmanial activity and mechanism in vitro. Cell viability assays with Leishmania donovani and Leishmania tarentolae promastigotes showed IC50 values in the low micromolar range (from 2.0 to 4.5 µM, respectively) with low toxicity to murine and J774A.1 macrophages. Electron paramagnetic resonance spectroscopy confirmed radical generation in the presence of low-molecular-weight iron compounds. However, this did not trigger the antileishmanial effect, as neither N-acetylcysteine nor pyridoxal isonicotinoyl hydrazone altered activity. Mitochondrial function(s) and superoxide production in Leishmania remained unaffected. Both endoperoxides significantly inhibited synthesis of 5-dehydroepisterol, the major sterol in Leishmania tarentolae, suggesting targeting of the sterol biosynthesis pathway. Their limited toxicity to mammalian macrophages makes ergosterol and dehydrocholesterol endoperoxides promising candidates for future antileishmanial drug development.
Open AccessSterol Endoperoxides and Their Antileishmanial Effects: Influence on Viability, Oxygen Metabolism and Sterol Synthesis
Leishmaniasis is a global health issue, especially in tropical and subtropical areas, with treatment challenges due to the development of resistance to current drugs. This has prompted the search for new antileishmanial compounds. Endoperoxides, due to parasites’ reliance on external iron and susceptibility to oxidative stress, are promising antileishmanial compounds. This study evaluated two sterol endoperoxides—ergosterol endoperoxide (ErgoEP) and dehydrocholesterol endoperoxide (DHCholEP)—for their antileishmanial activity and mechanism in vitro. Cell viability assays with Leishmania donovani and Leishmania tarentolae promastigotes showed IC50 values in the low micromolar range (from 2.0 to 4.5 µM, respectively) with low toxicity to murine and J774A.1 macrophages. Electron paramagnetic resonance spectroscopy confirmed radical generation in the presence of low-molecular-weight iron compounds. However, this did not trigger the antileishmanial effect, as neither N-acetylcysteine nor pyridoxal isonicotinoyl hydrazone altered activity. Mitochondrial function(s) and superoxide production in Leishmania remained unaffected. Both endoperoxides significantly inhibited synthesis of 5-dehydroepisterol, the major sterol in Leishmania tarentolae, suggesting targeting of the sterol biosynthesis pathway. Their limited toxicity to mammalian macrophages makes ergosterol and dehydrocholesterol endoperoxides promising candidates for future antileishmanial drug development.
- Open Access
- 9 March 2026
- Published by Springer Nature in Parasites & Vectors
- Vol. 19 (1)
Targeting mitochondrial bioenergetics: the “Achilles’ heel” of Leishmania
Background: The parasite Leishmania is the causative agent of leishmaniasis and relies on a single “mitochondrion” as its “powerhouse”. It also has a compromised antioxidant defense system. Consequently, potential therapeutic strategies include triggering mitochondrial dysfunction along with subversion of host metabolic bioenergetics; however, such information remains poorly defined. The focus of this study was to delineate the impact of antileishmanials amphotericin B (Ampho B) and miltefosine (hexadecylphosphocholine [HePC]) on the metabolic bioenergetics of Leishmania parasites vis-à-vis mammalian macrophages. Methods: In promastigotes, the redox status was evaluated by flow cytometry; levels of ATP were measured by chemiluminescence; and oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and substrate utilization were assessed by XFp Analyzer. In Leishmania donovani ( L. donovani )-infected macrophages, expression of metabolic bioenergetics related regulatory molecules was assessed by droplet digital polymerase chain reaction (ddPCR) and immunoblotting. Results: In promastigotes, at their respective 50% and 90% inhibitory concentrations (IC 50 and IC 90 ), Ampho B and HePC disrupted redox homeostasis, enhanced generation of mitochondrial superoxide, depleted OCR and ATP, and caused a greater degree of mitochondrial inhibition with HePC than with Ampho B. The L. donovani promastigotes sourced acetyl CoA primarily from the fatty acid oxidation pathway for mitochondrial tricarboxylic acid cycle, and inhibition of the mitochondrial fatty acid oxidation was higher with Ampho B. In L. donovani -infected macrophages, there was significantly increased expression of the Ampk axis ( Ampk – Lkb1 – Sirt1 ), mitochondrial biogenesis marker Pgc1α , and markers of oxidative phosphorylation ( Cox IV , Atp synthase ). The rate-limiting enzymes of glycolysis, namely HkII , Pfk , Pkm2 , and glucose transporter ( Glut1 ), were enhanced, but expression of Mtor was decreased. All markers of the Ampk axis and oxidative phosphorylation were significantly curtailed by both antileishmanials in favor of parasite clearance, whereas glycolytic markers remained unchanged; overall, the dampening of metabolic bioenergetics by HePC was greater than that caused by Ampho B. Conclusions: Targeting the “mitochondrion” and metabolic reprogramming are effective leishmanicidal strategies adopted by HePC and Ampho B, with the degree of inhibition by HePC exceeding that of Ampho B. Accordingly, screening for compounds capable of mediating metabolic reprogramming could augment the limited armamentarium of antileishmanials. Graphical
- 9 March 2026
- Published by Springer Nature in Parasites & Vectors
- Vol. 19 (1)
Open AccessTargeting mitochondrial bioenergetics: the “Achilles’ heel” of Leishmania
Background: The parasite Leishmania is the causative agent of leishmaniasis and relies on a single “mitochondrion” as its “powerhouse”. It also has a compromised antioxidant defense system. Consequently, potential therapeutic strategies include triggering mitochondrial dysfunction along with subversion of host metabolic bioenergetics; however, such information remains poorly defined. The focus of this study was to delineate the impact of antileishmanials amphotericin B (Ampho B) and miltefosine (hexadecylphosphocholine [HePC]) on the metabolic bioenergetics of Leishmania parasites vis-à-vis mammalian macrophages. Methods: In promastigotes, the redox status was evaluated by flow cytometry; levels of ATP were measured by chemiluminescence; and oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and substrate utilization were assessed by XFp Analyzer. In Leishmania donovani ( L. donovani )-infected macrophages, expression of metabolic bioenergetics related regulatory molecules was assessed by droplet digital polymerase chain reaction (ddPCR) and immunoblotting. Results: In promastigotes, at their respective 50% and 90% inhibitory concentrations (IC 50 and IC 90 ), Ampho B and HePC disrupted redox homeostasis, enhanced generation of mitochondrial superoxide, depleted OCR and ATP, and caused a greater degree of mitochondrial inhibition with HePC than with Ampho B. The L. donovani promastigotes sourced acetyl CoA primarily from the fatty acid oxidation pathway for mitochondrial tricarboxylic acid cycle, and inhibition of the mitochondrial fatty acid oxidation was higher with Ampho B. In L. donovani -infected macrophages, there was significantly increased expression of the Ampk axis ( Ampk – Lkb1 – Sirt1 ), mitochondrial biogenesis marker Pgc1α , and markers of oxidative phosphorylation ( Cox IV , Atp synthase ). The rate-limiting enzymes of glycolysis, namely HkII , Pfk , Pkm2 , and glucose transporter ( Glut1 ), were enhanced, but expression of Mtor was decreased. All markers of the Ampk axis and oxidative phosphorylation were significantly curtailed by both antileishmanials in favor of parasite clearance, whereas glycolytic markers remained unchanged; overall, the dampening of metabolic bioenergetics by HePC was greater than that caused by Ampho B. Conclusions: Targeting the “mitochondrion” and metabolic reprogramming are effective leishmanicidal strategies adopted by HePC and Ampho B, with the degree of inhibition by HePC exceeding that of Ampho B. Accordingly, screening for compounds capable of mediating metabolic reprogramming could augment the limited armamentarium of antileishmanials. Graphical